CD40-mediated tumor necrosis factor receptor-associated factor 3 signaling upregulates IL-4-induced germline Cε transcription in a human B cell line

被引:14
作者
Basaki, Y [1 ]
Ikizawa, K [1 ]
Kajiwara, K [1 ]
Yanagihara, Y [1 ]
机构
[1] Natl Sagamihara Hosp, Clin Res Ctr, Sagamihara, Kanagawa 2288522, Japan
关键词
CD40; TRAF3; ERK; MEK1; IL-4; germline C epsilon transcription;
D O I
10.1016/S0003-9861(02)00369-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Induction of germline Cepsilon transcription in B cells by IL-4, which is a critical initiating step for IgE class switching, is enhanced by CD40 engagement. Although signaling by CD40 is initiated by the binding of tumor necrosis factor receptor-associated factor (TRAF) family members to its cytoplasmic domain, whether those TRAF family proteins mediate enhancement of germline Cc transcription is not evident. We report here that CD40-induced TRAF3-dependent activation of mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) kinase 1 (MEK1) is involved in the upregulation of IL-4-driven germline Cepsilon transcription in a human Burkitt's lymphoma B cell line, DG75. Among the six known TRAF proteins, TRAF2, 3, 5. and 6 associated with CD40 in an unstimulated state, and the levels of these four proteins were unaffected by anti-CD40 stimulation. Antisense oligodeoxynucleotide (ODN) for TRAF3 inhibited CD40-induced activation of MEK1-ERK pathway by decreasing expression of TRAF3 protein, but antisense ODNs for TRAF2. 5, and 6 were ineffective. Furthermore, CD40-mediated enhancement of IL-4-driven germline Cepsilon; transcription was inhibited by antisense ODN for TRAF3 and by a MEK1 inhibitor, PD98059. These results suggest that in DG75 cells, TRAF3-induced MEK1 activation may be involved in CD40-mediated upregulation of IL-4-driven germline Cepsilon transcription, (C) 2002 Elsevier Science (USA) All rights reserved.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 22 条
  • [1] THE CD40 ANTIGEN AND ITS LIGAND
    BANCHEREAU, J
    BAZAN, F
    BLANCHARD, D
    BRIERE, F
    GALIZZI, JP
    VANKOOTEN, C
    LIU, YJ
    ROUSSET, F
    SAELAND, S
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 : 881 - 922
  • [2] Tumor necrosis factor receptor-associated factors (TRAFs)
    Bradley, JR
    Pober, JS
    [J]. ONCOGENE, 2001, 20 (44) : 6482 - 6491
  • [3] Tumour-necrosis-factor-receptor-associated factor 6, NF-κB-inducing kinase and IκB kinases mediate IgE isotype switching in response to CD40
    Brady, K
    Fitzgerald, S
    Moynagh, PN
    [J]. BIOCHEMICAL JOURNAL, 2000, 350 : 735 - 740
  • [4] An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-κB activation but is dispensable for c-Jun N-terminal kinase signaling
    Dadgostar, H
    Cheng, GH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) : 24775 - 24780
  • [5] Hsing Y, 1997, J IMMUNOL, V159, P4898
  • [6] TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling
    Ishida, T
    Tojo, T
    Aoki, T
    Kobayashi, N
    Ohishi, T
    Watanabe, T
    Yamamoto, T
    Inoue, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) : 9437 - 9442
  • [7] Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions
    Jalukar, SV
    Hostager, BS
    Bishop, GA
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (02) : 623 - 630
  • [8] TRAF2 is essential for JNK but not NF-kappa B activation and regulates lymphocyte proliferation and survival
    Lee, SY
    Reichlin, A
    Santana, A
    Sokol, KA
    Nussenzweig, MC
    Choi, Y
    [J]. IMMUNITY, 1997, 7 (05) : 703 - 713
  • [9] Leo E, 1999, EUR J IMMUNOL, V29, P3908, DOI 10.1002/(SICI)1521-4141(199912)29:12<3908::AID-IMMU3908>3.0.CO
  • [10] 2-E